Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) ...
Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...
With an estimated 1.5 lakh cases of oral cancer diagnosed annually in India and a high mortality rate due to late detection, ...
Researchers can easily track and isolate bit.bio's consistent, defined, and scalable human iPSC-derived cells for the first time, opening up new applications in neurodegenerative drug discovery. ioTra ...
DeepSeek was tasked with selecting two stocks investors can buy now and hold long-term due to their growth potential.